
FDA reverses course and will review Moderna’s mRNA flu shot, company says
CNN
The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday,
More Related News

Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that half the group got their medications earlier in the day, before 3 p.m., and the other half got them later.












